ZIRA: A new prognostic biomarker of estrogen receptor- positive (ER plus ) breast cancers

被引：0
|
作者：
Vendrell, J. [1 ]
Nguyen, N. T. [1 ]
Gyorffy, B. [3 ]
Leon, S. [2 ]
Grisard, E. [1 ]
Bachelot, T. [2 ]
Treilleux, I. [2 ]
Cohen, P. A. [1 ]
机构：
[1] Univ Lyon 1, Ctr Rech Cancerol Lyon, F-69365 Lyon, France
[2] Ctr Leon Berard, F-69373 Lyon, France
[3] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50569-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
649
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [31] Using Automated Image Analysis To Validate Ki67 as a Clinical Prognostic Biomarker for Estrogen-Receptor Positive Breast Cancers
    Magliocco, A. M.
    Kornaga, E. N.
    Klimowicz, A. C.
    Petrillo, S. K.
    Konno, M.
    Yau, A.
    CANCER RESEARCH, 2010, 70
  • [32] G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer
    Oshi, Masanori
    Takahashi, Hideo
    Tokumaru, Yoshihisa
    Yan, Li
    Rashid, Omar M.
    Matsuyama, Ryusei
    Endo, Itaru
    Takabe, Kazuaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [33] Late disease recurrence in estrogen receptor positive (ER plus ) premenopausal breast cancer (BC)
    Recchia, Francesco
    Candeloro, Giampiero
    Necozione, Stefano
    Rea, Silvio
    Hoo, William Soo
    Cantor, Tom
    CANCER RESEARCH, 2014, 74 (19)
  • [34] Elucidating the Mechanism of Action of Lenvatinib in Estrogen Receptor-Positive (ER plus ) Breast Cancer
    Gandasasmita, Natasha
    Vaidya, Gauri
    Datta, Arpita
    Marvalim, Charlie
    Lim, Joline Si Jing
    Lee, Soo Chin
    CANCER RESEARCH, 2024, 84 (08)
  • [35] Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER plus ) primary breast cancer and paired recurrence
    Dieci, Maria Vittoria
    Barbieri, Elena
    Goubar, Aicha
    Andre, Fabrice
    Omarini, Claudia
    Bettelli, Stefania Raffaella
    Piacentini, Federico
    Ficarra, Guido
    Conte, Pier Franco
    Guameri, Valentina
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers
    Itoh, Mitsuya
    Iwamoto, Takayuki
    Matsuoka, Junji
    Nogami, Tomohiro
    Motoki, Takayuki
    Shien, Tadahiko
    Taira, Naruto
    Niikura, Naoki
    Hayashi, Naoki
    Ohtani, Shoichiro
    Higaki, Kenji
    Fujiwara, Toshiyoshi
    Doihara, Hiroyoshi
    Symmans, W. Fraser
    Pusztai, Lajos
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 143 (02) : 403 - 409
  • [37] Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers
    Mitsuya Itoh
    Takayuki Iwamoto
    Junji Matsuoka
    Tomohiro Nogami
    Takayuki Motoki
    Tadahiko Shien
    Naruto Taira
    Naoki Niikura
    Naoki Hayashi
    Shoichiro Ohtani
    Kenji Higaki
    Toshiyoshi Fujiwara
    Hiroyoshi Doihara
    W. Fraser Symmans
    Lajos Pusztai
    Breast Cancer Research and Treatment, 2014, 143 : 403 - 409
  • [38] Characterization of Estrogen Receptor Positive/Progesterone Receptor Negative/(ER plus /PR-) Breast Cancer (BC)
    Shen, Tiansheng
    Guo, Tao
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    LABORATORY INVESTIGATION, 2016, 96 : 72A - 73A
  • [39] Characterization of Estrogen Receptor Negative/Progesterone Receptor Positive/(ER-/PR plus ) Breast Cancer (BC)
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene
    Wei, Shi
    MODERN PATHOLOGY, 2015, 28 : 65A - 65A
  • [40] Characterization of Estrogen Receptor Positive/Progesterone Receptor Negative/(ER plus /PR-) Breast Cancer (BC)
    Shen, Tiansheng
    Guo, Tao
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    MODERN PATHOLOGY, 2016, 29 : 72A - 73A
12345